Back to Full Staff

Brian S. Feldman

Policy Analyst & Researcher-Reporter

Brian S. Feldman is a policy analyst & researcher-reporter with the Open Markets Institute. He previously worked for an education technology company in Cleveland, Ohio through Venture for America, an entrepreneurship fellowship centered on regional economies. He graduated from Washington University St. Louis where he received a dual degree in classics and philosophy-neuroscience-psychology.

His writing on antitrust policy, regional inequality, pharmacy benefit manager (PBM) consolidation, and entrepreneurship has appeared in The Atlantic, Quartz, Washington Monthly, BBC Future, and Matter, among other outlets. The Wall Street Journal, Washington Post, NPRSlate, congressional testimony, and two class-action lawsuits have cited his work.


Latest Work


clippings

Why CVS Wants to Buy Aetna

Date Published: January 27, 2018

Brian Feldman, of the antitrust research group Open Markets Institute, argues that mergers in the past few decades have “created a funhouse mirror situation—the drug industry’s incentives have become incredibly warped.” The market for drugs is shaped by five different types of companies: drug manufacturers, wholesalers, pharmacies, insurers, and pharmacy benefit managers (which function as middlemen between manufacturers and insurers). If the CVS-Aetna deal goes through, Feldman argues, CVS would have a foothold in every category but manufacturing, meaning that it would encounter competition from other companies less often.

Continue Reading

Join the Movement


In America today, wealth and political power are more concentrated than at any point in our country’s history.

The Open Markets Institute, formerly the Open Markets program at New America, was founded to protect liberty and democracy from these extreme -- and growing -- concentrations of private power.

Stay updated


Sign up to stay informed.